Skip to content

✨ FREE POSTAGE ABOVE RM110✨


    Salicylic Acid 2% Anhydrous Solution

    RM40.00 RM80.00
    Unit price  per 

    Water-free serum for gentle exfoliation and pore decongestion

    The Ordinary Salicylic Acid 2% Anhydrous Solution is a water-free product formulated to exfoliate the skin and help decongest pores. Direct acids, specifically alpha hydroxy acids (AHAs) and beta hydroxy acids (BHAs), are renowned for their ability to support the natural shedding of dead skin. While AHAs aim to promote superficial exfoliation, Salicylic Acid (SA), a lipophilic BHA, is particularly effective at targeting oil within the pores that can lead to congestion. The Ordinary Salicylic Acid 2% Anhydrous Solution offers salicylic acid in a squalane base formulated with the intent of reducing concerns of skin irritation that can be associated with the use of SA.

    Apply in the morning and evening. Apply a small dot to the target area or apply a small amount over the face for general use. Do not use on sensitive, peeling or compromised skin. Avoid the eye contour and contact with eyes. Patch testing prior to use is advised: Apply the product as directed to a small area once a day for three days to test if you are sensitive to this product. If you develop irritation, hives, swelling of eyes and mouth, blistering, or difficulty breathing, rinse off, cease use, and consult a physician right away. Keep out of reach of children.

    Sunburn Alert: This product contains a beta hydroxy acid (BHA) that may increase your skin's sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterwards.

    Authentic Products

    We sell authentic products only.

    Shop now with Interest-Free Instalments

    Make 3 interest-free instalments when you check out with Pace.

    Personal Shopper Service

    Need a Personal Shopper from the US? Leave the Shopping to us.

    Fast Shipping

    Pay Today, Ship Tomorrow.